| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/05/2001 | CN1311682A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol |
| 09/05/2001 | CN1311680A Pyrrolo [2,3d] pyrimidine compositions and their use |
| 09/05/2001 | CN1311678A Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 09/05/2001 | CN1311676A Compound that inhibit the binding of integrins to their receptors |
| 09/05/2001 | CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid |
| 09/05/2001 | CN1311629A Inhibitors of transcription factor NF-KB |
| 09/05/2001 | CN1311257A Double specific monoclonal anti-body, its preparing method and thromobolysin made therefrom |
| 09/05/2001 | CN1311209A New polypeptide-human ataxia-telangiectatic mutation protein 9 and polynucleotide for coding said polypeptide |
| 09/05/2001 | CN1311024A Tea for anti-thrombus and thinning blood and preparing method |
| 09/05/2001 | CN1311016A Traditional Chinese medicine for curing viral myocarditis and its preparing process |
| 09/05/2001 | CN1311013A Medicine for curing rheumatism, rheumatoid and apoplexy sequel |
| 09/05/2001 | CN1311006A Active pseudo-ginseng |
| 09/05/2001 | CN1070492C Tetracylic derivatives, process for prepn. of same and use |
| 09/05/2001 | CN1070487C Hexahydronaphthalene ester derivatives, their prepn. and their therapeutic uses |
| 09/05/2001 | CN1070484C Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 09/05/2001 | CN1070380C Method for prodn. of HDL |
| 09/05/2001 | CN1070375C Emulsion for lowering blood-lipid, and method for preparing same |
| 09/05/2001 | CN1070373C Health-care oral liquid-contg. the fruit of Chinese wolfberry and prepn. method therefor |
| 09/05/2001 | CN1070367C Injection adhesion and method for preparing same |
| 09/04/2001 | US6285537 Stress-follower circuit configuration |
| 09/04/2001 | US6284790 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same |
| 09/04/2001 | US6284785 1-arenesulfonyl-2-aryl-pyrrolidine and pyridine derivatives |
| 09/04/2001 | US6284778 Neurotrophic agent |
| 09/04/2001 | US6284774 4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists |
| 09/04/2001 | US6284766 9H-pyrimido [4,5-b] indole derivatives: CRF1 specific ligands |
| 09/04/2001 | US6284760 Method of treating schizophrenia, depression and other neurological conditions |
| 09/04/2001 | US6284757 Antiserotinone agent |
| 09/04/2001 | US6284743 Method for modulating smooth muscle cell proliferation |
| 09/04/2001 | US6284725 Administering binding compound for glucagon receptor such asglucagon-like peptide |
| 09/04/2001 | US6284540 Neuronal trophic support and cell differentiation by introducing nucleotide sequence |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284464 Inhibition of binding of Hox and homeodomain-containing proteins and uses thereof |
| 09/04/2001 | US6284268 Cyclosporin, synergistic |
| 09/04/2001 | CA2037410C Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 08/30/2001 | WO2001062954A2 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 08/30/2001 | WO2001062949A1 Method of purifying a fermentation broth |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062913A1 Vertebrate globin |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062799A2 Method for inhibiting angiogenesis using molecules that enhance plasmin activity |
| 08/30/2001 | WO2001062796A1 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis |
| 08/30/2001 | WO2001062793A2 Estrogen receptor beta variants and methods of detection thereof |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062779A2 New transcription factor carp-2 |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |
| 08/30/2001 | WO2001062768A1 2-thioether a2a receptor agonists |
| 08/30/2001 | WO2001062758A1 Pteridine compounds for the treatment of psoriasis |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062756A1 Pyridinylimidazoles |
| 08/30/2001 | WO2001062751A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 08/30/2001 | WO2001062750A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 08/30/2001 | WO2001062744A2 Substituted piperazine compounds |
| 08/30/2001 | WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 08/30/2001 | WO2001062741A1 Tetrahydronaphtalene derivatives and their use |
| 08/30/2001 | WO2001062740A1 Mibefradil analogues and their use |
| 08/30/2001 | WO2001062737A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
| 08/30/2001 | WO2001062736A1 Aryl fused azapolycyclic compounds |
| 08/30/2001 | WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062726A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 08/30/2001 | WO2001062721A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062718A1 Benzamide derivative and use thereof |
| 08/30/2001 | WO2001062717A1 Aminosulfonylbiphenyl derivatives |
| 08/30/2001 | WO2001062714A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062712A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands |
| 08/30/2001 | WO2001062706A1 Aminoadamantane derivatives as therapeutic agents |
| 08/30/2001 | WO2001062705A2 Aminoalcohol derivatives |
| 08/30/2001 | WO2001062341A2 Combination product for the treatment of obesity |
| 08/30/2001 | WO2001062298A2 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 08/30/2001 | WO2001062292A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062262A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 08/30/2001 | WO2001062256A1 Novel galenical form for oral administration with prolonged release of molsidomine |
| 08/30/2001 | WO2001062251A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062250A1 Thiazolium compounds and treatments of disorders associated with protein aging |
| 08/30/2001 | WO2001062245A2 Bilirubin or biliverdin degradation fragments |
| 08/30/2001 | WO2001062236A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent |
| 08/30/2001 | WO2001062233A2 Adenosine receptor modulators |
| 08/30/2001 | WO2001016335A3 Stromelysin-homologous novel mmp-27 matrix metalloproteinase |
| 08/30/2001 | WO2001013031A3 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 08/30/2001 | WO2001012195A3 Use of morphine derivatives as medicaments for the treatment of neuropathic problems |
| 08/30/2001 | WO2001010430A3 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 08/30/2001 | WO2001010378A3 Controlled release from copolymers of acrylic or methacrylic acid/l-dopa, acrylic or methacrylic acid/l-$g(a)-methyl dopa, acrylic or methacrylic acid/carbidopa and their combinations |
| 08/30/2001 | WO2000074701A3 Method and composition for inhibiting cardiovascular cell proliferation |
| 08/30/2001 | WO2000071510A3 INHIBITORS OF FACTOR Xa |
| 08/30/2001 | WO2000040733A9 Human cyclic nucleotide pdes |
| 08/30/2001 | WO2000040597A9 Method and composition for angiogenesis inhibition |
| 08/30/2001 | US20010018522 Neuropeptide y receptor ligand |
| 08/30/2001 | US20010018449 Hypotensive agent, endothelial damage, arteriosclerosis, antidiabetic agents |
| 08/30/2001 | US20010018447 Il-8 receptor antagonists |
| 08/30/2001 | US20010018430 Anticancer agents, psoriasis, restenosis, atherosclerosis |
| 08/30/2001 | US20010018429 Neurotransmitter |
| 08/30/2001 | US20010018428 C-pyrazole A2A receptor agonists |
| 08/30/2001 | US20010018427 Anticholesterol agent |
| 08/30/2001 | US20010018418 Method of promoting angiogenesis |
| 08/30/2001 | DE10008329A1 New aminosulfonyl-biphenyl derivatives are Factor Xa and Factor VIIa inhibitors useful e.g. for treating thrombosis, myocardial infarction, arteriosclerosis, inflammation or angina pectoris |
| 08/30/2001 | CA2657986A1 Substituted piperazine compounds |